ArticleEmerging infectious diseases2007
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.
Article in Emerging infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 55 citations in OpenAlex.
- Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial.PLoS medicine · 2018Trial
- Molecular detection of fluoroquinolone-resistantFrontiers in cellular and infection microbiology · 2022Article
- Susceptibilities of invasiveJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021Article
- Meningococcal Quinolone Resistance Originated from Several CommensalAntimicrobial agents and chemotherapy · 2020Article
- Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis.GMS infectious diseases · 2020Article
- Mass chemoprophylaxis for control of outbreaks of meningococcal disease.The Lancet. Infectious diseases · 2018Review
- Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.Open forum infectious diseases · 2015Article
- Article
- Phasevarions mediate epigenetic regulation of antimicrobial susceptibility in Neisseria meningitidis.Antimicrobial agents and chemotherapy · 2014Article
- Invasive meningococcal infection: analysis of 110 cases from a tertiary care centre in North East India.Indian journal of pediatrics · 2013Article
- Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.Antimicrobial agents and chemotherapy · 2013Article
- Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.PloS one · 2013Article
- Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Infection · 2012Review
- Meningococcal disease in Asia: an under-recognized public health burden.Epidemiology and infection · 2011Review
- Imported ciprofloxacin-resistant Neisseria meningitidis.Emerging infectious diseases · 2009Article
- Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.Antimicrobial agents and chemotherapy · 2009Article
- Emerging antibiotic resistance in bacteria with special reference to India.Journal of biosciences · 2008Review
- Emerging and re-emerging bacterial diseases in India.Journal of biosciences · 2008Review
- Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin.Emerging infectious diseases · 2008Article
- Ciprofloxacin resistance in Neisseria meningitidis, France.Emerging infectious diseases · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Decreased susceptibility of Neisseria meningitidis isolates to ciprofloxacin emerged from an outbreak in Delhi, India. Results of antimicrobial susceptibility testing of the meningococcal isolates to ciprofloxacin and further sequencing of DNA gyrase A quinolone-resistance-determining region confirmed the emergence of ciprofloxacin resistance in the outbreak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.